FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry and molecular biology. Proposed is the use of a nucleic acid molecule capable of binding to SDF-1 and blocking the interaction between SDF-1 and SDF-1 CXCR7 receptor.
EFFECT: invention may be used to treat and / or prevent cancer.
34 cl, 18 dwg, 1 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SDF-1 BINDING NUCLEIC ACIDS | 2007 |
|
RU2590709C2 |
| SDF-1 BINDING NUCLEIC ACIDS AND USE THEREOF | 2008 |
|
RU2612388C2 |
| MCP-1 BINDING NUCLEIC ACID AND USING IT | 2008 |
|
RU2542973C2 |
| NEW CONNECTING C5a NUCLEIC ACIDS | 2013 |
|
RU2645261C2 |
| CXCL8-BINDING NUCLEIC ACIDS | 2019 |
|
RU2815444C2 |
| ANTI-CXCR4 ANTIBODIES AND USING THEM FOR TREATING CANCER | 2009 |
|
RU2573897C2 |
| IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY | 2013 |
|
RU2644686C2 |
| ANTI-CXCR4 ANTIBODIES FOR TREATMENT OF HIV INFECTION | 2010 |
|
RU2573902C2 |
| HUMANISED ANTI-CXCR4 ANTIBODIES FOR TREATING CANCER | 2011 |
|
RU2595394C2 |
| I-3859 ANTIBODY APPLICATION FOR CANCER DETECTION AND DIAGNOSTICS | 2012 |
|
RU2636032C2 |
